Moreover, the up-regulation of GPR158 in prostate cancer (PCa) and ovarian carcinoma indirectly affects the endocrine system (Patel et al., 2015; Engqvist et al., 2019). This evidence concerns the gene GPR158 and prostate carcinoma.